Targeted News Service logo

-- Preview Email Newsletter
Research from International Colleges Newsletter for 2026-07-13 ( 3 items )  
Eight Royal College Fellows Appointed to the Order of Canada for Outstanding Contributions to Medicine (10)
OTTAWA, Ontario, July 11 -- The Royal College of Physicians and Surgeons of Canada issued the following news: * * * Order of Canada: Fellow inductees On June 26, 2026, the Governor General announced the newest appointments to the Order of Canada, which recognizes outstanding achievement, dedication to the community and service to the nation. We're proud to share that eight Royal College Fellows are among this year's appointees, whose work spans transplant medicine, Anesthesiology, Cardiology, gynecologic oncology, neuropsychiatry, endocrine  more PR

HKU MILES-Shenzhen Pioneers Novel Super-Inert Fluorescent Dye For Clearer Ureter Imaging during Surgical Navigation (10)
HONG KONG, July 12 -- The University of Hong Kong issued the following news release: * * * HKU MILES-Shenzhen Pioneers Novel Super-Inert Fluorescent Dye For Clearer Ureter Imaging during Surgical Navigation * A cross-disciplinary research team led by Professor Hongjie DAI, Director of The Materials Institute of Life Sciences and Energy (MILES) of The University of Hong Kong (HKU) in Shenzhen, has developed a promising near-infrared (NIR) fluorescent dye for potential clinical application in ureter imaging during surgical navigation. The n more PR

Western University: Biochemistry Professor O'Donoghue Discusses Genetic Tools and Treatments for Huntington's Disease in Q&A (10)
LONDON, Canada, July 11 -- Western University issued the following Q&A on July 10, 2026, involving Patrick O'Donoghue, biochemistry professor and Huntington Society of Canada Research chair: * * * Huntington Society of Canada Research Chair advances innovative approaches to future treatment Western biochemistry professor Patrick O'Donoghue drives greater understanding of Huntington's disease with new route to suppress toxic huntingtin protein By Megan Stacey With a goal to accelerate life-changing treatments and advance patient care outco more PR